Robert Bryan Eisman

Ambac Financial Group, Inc. (“Ambac”), headquartered in New York City, is a holding company whose subsidiaries, including its principal operating subsidiary, Ambac Assurance Corporation (“Ambac Assurance”), Everspan Financial Guarantee Corporation, and Ambac Assurance UK Limited, provided financial guarantees and other financial services to clients in both the public and private sectors globally. Ambac Assurance, including the Segregated Account of Ambac Assurance (in rehabilitation), is a guarantor of public finance and structured finance obligations. Ambac is also exploring opportunities involving the development or acquisition of new financial services businesses.

Ambac Financial Group, Inc. is a holding company, which engages in the provision of financial guarantees and other financial services. It operates through the Financial Guarantee and Financial Services bussiness segments. The Financial Guarantee segment provides financial guarantees for public finance, structured finance, and international obligations. The Financial Services segment offers investment agreements, funding conduits, interest rate, and currency swaps to clients of the financial guarantee business. The company was founded on April 29, 1991 and is headquartered in New York, NY.

Garber Venture Capital manages the Garber Fund. The fund is used within a course environment for Smeal College of Business MBA students to experience all aspects of venture capital investing including deal sourcing, due diligence, term sheet negotiations, closing, monitoring investments, engineering exits and managing the portfolio. Since July 2002, the fund has made 7 investments and currently has 4 active investments. The fund's active investments include: (1) Healthy Humans LLC, a software platform that links patients to their physicians (2) Diamond Back Truck Accessories, a manufacturer and distributor of pick-up truck covers and other truck accessories (3) INDIGO Biosciences, which has developed a unique method to cryogenically preserve nuclear receptor cells and (4) HireVue, an on-line platform for executive recruitment. Initial investments typically range from $100,000 and $325,000 and are structured in the form of convertible debt or preferred stock.